Skip to main content
Log in

Symptomatic spinal metastases of intracranial glioblastoma: clinical characteristics and pathomechanism relating to GFAP expression

  • Case Report
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To demonstrate clinical characteristics of symptomatic spinal metastases of intracranial glioblastoma multiforme (GBM) and different spreading mechanisms relating to astrocytic cell differentiation, we present an extraordinary case of a 47-year-old patient with rapid progressive paraplegia due to coincident intramedullary and leptomeningeal dissemination of a supratentorial GBM. Serial biopsies of the intracranial, leptomeningeal, and intramedullary GBM lesions of our patient were analyzed for glial fibrillary acidic protein (GFAP). Furthermore, we present 19 additional cases of intracranial GBM with symptomatic spinal seeding, identified through literature review. GFAP expression was high in intracranial and intramedullary tumors, but low in leptomeningeal dissemination of our patient. Mean patient age was 45 years. Mean interval between identification of spinal metastases and death was 4.5 months. Mean overall survival was 18.6 months. Location of symptomatic spinal metastases was more frequently leptomeningeal (14 cases) than intramedullary (7 cases). The case presented herein supports the hypothesis of higher incidence of low GFAP expression in GBM cells in leptomeningeal manifestations after primary intracranial GBM. Because of the proposed tendency for early leptomeningeal spread from primary tumors with low astrocytic differentiation (low GFAP expression), patients with these tumors should be followed more closely to identify leptomeningeal tumor progression early on. Early identification of leptomeningeal spread could enable these patients to benefit from radiation therapy before they develop severe neurological deficits, which might translate into longer acceptable quality of life for these mostly young patients. This is an important finding, but further prospective studies are needed to verify our observations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas Incidence, diagnosis and outcome. Acta Neurochir (Wien) 126(2–4):84–92

    Article  CAS  Google Scholar 

  2. Balhuizen JC, Bots GT, Schaberg A, Bosman FT (1978) Value of cerebrospinal fluid cytology for the diagnosis of malignancies in the central nervous system. J Neurosurg 48(5):747–753

    Article  CAS  PubMed  Google Scholar 

  3. Banczerowski P, Simó M, Sipos L, Slowik F, Benoist G, Veres R (2003) Primary intramedullary glioblastoma multiforme of the spinal cord: report of eight cases. Ideggyogy Sz 56(1–2):28–32

    PubMed  Google Scholar 

  4. Buhl R, Barth H, Hugo HH, Hutzelmann A, Mehdorn HM (1998) Spinal drop metastases in recurrent glioblastoma multiforme. Acta Neurochir (Wien) 140(10):1001–1005

    Article  CAS  Google Scholar 

  5. Elliott JP, Keles GE, Waite M, Temkin N, Berger MS (1994) Ventricular entry during resection of malignant gliomas: effect on intracranial cerebrospinal fluid tumor dissemination. J Neurosurg 80(5):834–839

    Article  CAS  PubMed  Google Scholar 

  6. Hamilton MG, Tranmer BI, Hagen NA (1993) Supratentorial glioblastoma with spinal cord intramedullary metastasis. Can J Neurol Sci 20(1):65–68

    CAS  PubMed  Google Scholar 

  7. Hübner F, Braun V, Richter HP (2001) Case reports of symptomatic metastases in four patients with primary intracranial gliomas. Acta Neurochir (Wien) 143(1):25–29

    Article  Google Scholar 

  8. Jung T-Y, Jung S, Kim I-Y, Kang S-S, Kim S-H (2007) High grade gliomas: neuraxis dissemination pattern and prognosis. Neurosurg Q 17(3):151–155

    Article  Google Scholar 

  9. Karaca M, Andrieu MN, Hicsonmez A, Guney Y, Kurtman C (2006) Cases of glioblastoma multiforme metastasizing to spinal cord. Neurol India 54(4):428–430

    Article  PubMed  Google Scholar 

  10. Kocher M, Frommolt P, Borberg SK, Rühl U, Steingräber M, Niewald M, Staar S, Stuschke M, Becker G, Fischedick AR, Herfarth K, Grauthoff H, Müller RP (2008) Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma. Strahlenther Onkol 184(11):572–579

    Article  PubMed  Google Scholar 

  11. Lam CH, Cosgrove GR, Drislane FW, Sotrel A (1991) Spinal leptomeningeal metastasis from cerebral glioblastoma. Appearance on magnetic resonance imaging. Surg Neurol 35(5):377–380

    Article  CAS  PubMed  Google Scholar 

  12. Lindsay A, Holthouse D, Robbins P, Knuckey N (2002) Spinal leptomeningeal metastases following glioblastoma multiforme treated with radiotherapy. J Clin Neurosci 9(6):725–728

    Article  PubMed  Google Scholar 

  13. Onda K, Tanaka R, Takahashi H, Takeda N, Ikuta F (1989) Cerebral glioblastoma with cerebrospinal fluid dissemination: a clinicopathological study of 14 cases examined by complete autopsy. Neurosurgery 25(4):533–540

    Article  CAS  PubMed  Google Scholar 

  14. Pohar S, Taylor W, Chandan VS, Shah H, Sagerman RH (2004) Primary presentation of glioblastoma multiforme with leptomeningeal metastasis in the absence of previous craniotomy: a case report. Am J Clin Oncol 27(6):640–641

    Article  PubMed  Google Scholar 

  15. Schwaninger M, Patt S, Henningsen P, Schmidt D (1992) Spinal canal metastases: a late complication of glioblastoma. J Neurooncol 12(1):93–98

    Article  CAS  PubMed  Google Scholar 

  16. Stark AM, Nabavi A, Mehdorn HM, Blömer U (2005) Glioblastoma multiforme—report of 267 cases treated at a single institution. Surg Neurol 63(2):162–169

    Article  PubMed  Google Scholar 

  17. Stark AM, Maslehaty H, Hugo HH, Mehdorn HM (2010) Glioblastoma of the cerebellum and brainstem: report of seven cases and review of the literature. J Clin Neurosci 17(10) (expected publication)

  18. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) European Organisation for Research, Treatment of Cancer Brain Tumor, Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

    Article  CAS  PubMed  Google Scholar 

  19. Toledano Delgado R, Garcia N, Riva-Amarante E, Rodríguez Pascual J, García Leal R, Sendra Tello J (2006) Spinal leptomeningeal metastasis from cerebral glioblastoma: case report. Neurologia 21(7):378–381

    CAS  PubMed  Google Scholar 

  20. Vertosick FT Jr, Selker RG (1990) Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 27(4):516–521

    Article  PubMed  Google Scholar 

  21. Wagner S (2006) Secondary dissemination in children with high grade malignant gliomas and diffuse intrinsic pontine gliomas. Br J Cancer 95(8):991–997

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Professor Hans Landolt, head of the Department of Neurosurgery, Kantonsspital Aarau, Switzerland for his support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Homajoun Maslehaty.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maslehaty, H., Cordovi, S. & Hefti, M. Symptomatic spinal metastases of intracranial glioblastoma: clinical characteristics and pathomechanism relating to GFAP expression. J Neurooncol 101, 329–333 (2011). https://doi.org/10.1007/s11060-010-0257-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0257-y

Keywords

Navigation